Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 17.55
-0.15 (-0.85%)
Sep 8, 2026, 1:30 PM CST
Adimmune Market Cap
Adimmune has a market cap or net worth of 7.4 billion as of September 8, 2026. Its market cap has decreased by -4.36% in one year.
Market Cap
7.40B
Enterprise Value
8.57B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.55
ChartMarket Cap Chart
Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 7.40B, a decrease of -33.34%. That is a compound annual growth rate of -2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 7.40B | -7.39% |
| Dec 31, 2025 | 7.99B | -5.72% |
| Dec 31, 2024 | 8.47B | -39.37% |
| Dec 29, 2023 | 13.97B | -7.97% |
| Dec 30, 2022 | 15.18B | -20.83% |
| Dec 30, 2021 | 19.18B | -20.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 8.86B |
| TWi Biotechnology | 8.44B |
| Tanvex BioPharma | 8.37B |
| PharmaEngine | 8.19B |
| Locus Cell | 7.85B |
| Acepodia | 7.75B |
| TaiGen Biopharmaceuticals Holdings | 6.53B |
| AnnJi Pharmaceutical | 6.39B |